Evidence of Stem Cells Mobilization in the Blood of Patients with Pancreatitis: A Potential Link with Disease Severity

Table 4

The levels of chemoattractive factors in patients.

	SDF1α; [ng/mL]	C3a [ng/mL]	C5a [ng/mL]	MAC [ng/mL]	S1P [nmol/mL]	HGF [ng/mL]
CG	2.6 (2.4-2.9)	992.3 (845.6-1103)	134.4 (77.3-189.3)	3412.6 (2486-5145)	6.0 (5.8-6.5)	1.3 (1.1-1.3)
AP	2.7 (2.3-3.0)	891.6 (771-1030.3)	120.2 (94.8-176.4)	4293.0 (2645.8-5951)	6.1 (4.8-8.2)	2.6 (1.3-3.6)
MAP	2.8 (2.3-3.0)	890.1 (791.4-1006.6)	114.3 (86.6-149.6)	4631.5 (2929.1-5974.3)	7.3 (4.6-8.8)	2.7 (1.7-3.3)
SAP	2.7 (2.3-3.3)	891.7 (731-1102)	137.3 (120.2-191.2)	3163.7 (2381.9-5019.6)	5.9 (5.0-6.9)	2.3 (0.9-5.2)
CP	3.1 (2.7-3.9)	953.3 (619.3-1881.8)	136.2 (90.5-183.3)	3408.0 (2758.7-4336.4)	6.3 (5.6-7.4)	1.0 (0.7-1.9)

AP: acute pancreatitis; C: complement; CG: control group; CP: chronic pancreatitis; HGF: hepatocyte growth factor; MAC: membrane attacking complex; MAP: moderate acute pancreatitis; S1P: sphingosine-1-phosphate; SAP: severe acute pancreatitis; SDF: stromal-derived factor 1α. Values are presented as median (Q1-Q3). vs. healthy controls.